Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery

Journal of Neurosurgery

Volumn 118, Issue 4, 2013, Pages 830-837

  Sheehan, Jason P ^a,b   Xu, Zhiyuan ^a   Popp, Britney ^a   Kowalski, Leigh ^a   Schlesinger, David ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Glioblastoma; Glioma; Mibefradil; Oncology; Radiosurgery; Rat

Indexed keywords

MIBEFRADIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER SIZE; CANCER SURVIVAL; CELL DEATH; CONTROLLED STUDY; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HISTOPATHOLOGY; IN VITRO STUDY; IONIZING RADIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RAT; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; BRAIN NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; MAGNETIC RESONANCE IMAGING; MIBEFRADIL; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RATS; RATS, SPRAGUE-DAWLEY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875842518     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.11.JNS121087     Document Type: Article

References (33)

1. Barth RF, Kaur B: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299-312, 2009
2. Berridge MJ: Calcium signaling and cell proliferation. Bioessays 17:491-500, 1995
3. 2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 62:210-219, 2002
4. Dinapoli RP, Brown LD, Arusell RM, Earle JD, O'Fallon JR, Buckner JC, et al: Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for highgrade glioma. J Clin Oncol 11:1316-1321, 1993
5. Farrell CL, Stewart PA, Del Maestro RF: A new glioma model in rat: the C6 spheroid implantation technique permeability and vascular characterization. J Neurooncol 4:403-415, 1987
6. Fei H, Zhao B, Zhao S, Wang Q: Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1beta-induced beta-cell apoptosis. Mol Cell Biochem 315: 75-84, 2008
7. Gray LS, Macdonald TL: The pharmacology and regulation of T type calcium channels: new opportunities for unique therapeutics for cancer. Cell Calcium 40:115-120, 2006
8. Himmel HM, Stengel W, Ravens U: Selectivity of blocking of low- versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma - glioma NG 108-15 cells. Pharmacol Res 44: 113-116, 2001
9. Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ: Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev 45:143-163, 2004
10. Keir ST, Reardon DA, Saling JR, Gray LS, Bigner DD, Friedman HS: Mibefradil, a novel therapy for glioblastoma multiforme: interlaced therapy in a murine model. Neuro Oncol 13 (Suppl 3):iii108-iii109, 2011 (Abstract)
11. Khan N, Li H, Hou H, Lariviere JP, Gladstone DJ, Demidenko E, et al: Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation. Int J Radiat Oncol Biol Phys 73:878-885, 2009
12. Kondziolka D, Lunsford LD, Claassen D, Maitz AH, Flickinger JC: Radiobiology of radiosurgery: Part I. The normal rat brain model. Neurosurgery 31:271-279, 1992
13. Lee GL, Hait WN: Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin. Life Sci 36:347-354, 1985
14. 2+) channels inhibits human ovarian cancer cell proliferation. Cancer Invest 29:339-346, 2011
15. Lijnen P, Fagard R, Petrov V: Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells. J Cardiovasc Pharmacol 33:595-604, 1999
16. Lonneth R, Bkaily G, Sperelakis N, Liwnicz BH, Gruenstein E: Electrophyisiological and biochemical characterization of a continuous human astrocytoma cell line with many properties of well-differentiated astrocytes. Brain Res 486:95-107, 1989
17. McRory JE, Santi CM, Hamming KS, Mezeyova J, Sutton KG, Baillie DL, et al: Molecular and functional characterization of a family of rat brain T-type calcium channels. J Biol Chem 276:3999-4011, 2001
18. Mullins ME, Horowitz BZ, Linden DH, Smith GW, Norton RL, Stump J: Life-threatening interaction of mibefradil and b-blockers with dihydropyridine calcium channel blockers. JAMA 280:157-158, 1998
19. Narayana A, Golfinos JG, Fischer I, Raza S, Kelly P, Parker E, et al: Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. Int J Radiat Oncol Biol Phys 72:383-389, 2008
20. Nebe B, Kunz F, Peters A, Rychly J, Noack T, Beck R: Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells. Graefes Arch Clin Exp Ophthalmol 242:597-604, 2004
21. 2+)- and volume-activated Cl- channels in macrovascular endothelial cells. Br J Pharmacol 121:547-555, 1997
22. Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, Wurster RD: Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37:105-119, 2005
23. Panner A, Wurster RD: T-type calcium channels and tumor proliferation. Cell Calcium 40:253-259, 2006
24. + channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 510:93-102, 1998
25. Santoni G, Santoni M, Nabissi M: Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy. Br J Pharmacol 166:1244-1246, 2012
26. Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, et al: HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res 9:259-270, 2011
27. Sheehan J, Ionescu A, Pouratian N, Hamilton DK, Schlesinger D, Oskouian RJ Jr, et al: Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation. J Neurosurg 108:972-978, 2008
28. Taylor JT, Zeng XB, Pottle JE, Lee K, Wang AR, Yi SG, et al: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 14:4984-4991, 2008
29. Tryggestad E, Armour M, Iordachita I, Verhaegen F, Wong JW: A comprehensive system for dosimetric commissioning and Monte Carlo validation for the small animal radiation research platform. Phys Med Biol 54:5341-5357, 2009
30. Vilner BJ, John CS, Bowen WD: Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 55:408-413, 1995
31. Wondergem R, Gong W, Monen SH, Dooley SN, Gonce JL, Conner TD, et al: Blocking swelling-activated chloride current inhibits mouse liver cell proliferation. J Physiol 532:661-672, 2001
32. Wong J, Armour E, Kazanzides P, Iordachita I, Tryggestad E, Deng H, et al: High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys 71:1591-1599, 2008
33. 2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br J Pharmacol 166:1247-1260, 2012